CN Patent

CN108129514A — 磷酸/膦酸衍生物的单一异构体及其医药用途

Assigned to BEIJING MEIBEITA PHARMACEUTICAL RESEARCH Co Ltd · Expires 2018-06-08 · 8y expired

What this patent protects

本发明涉及式Ia所示的磷酸/膦酸衍生物及其非毒性药学上可接受的盐；其中，式Ib所示的非对映异构体的含量小于2％： 结构式Ia和Ib中，Ar代表取代或未取代的苯环或萘环，R 1 代表H或碳原子数1‑6的烷基；R 2 代表碳原子数1‑6的烷基或环烷基；D代表含磷酸/膦酸基的药理活性分子的残基，即 代表含磷酸/膦酸基的药理活性分子。

USPTO Abstract

本发明涉及式Ia所示的磷酸/膦酸衍生物及其非毒性药学上可接受的盐；其中，式Ib所示的非对映异构体的含量小于2％： 结构式Ia和Ib中，Ar代表取代或未取代的苯环或萘环，R 1 代表H或碳原子数1‑6的烷基；R 2 代表碳原子数1‑6的烷基或环烷基；D代表含磷酸/膦酸基的药理活性分子的残基，即 代表含磷酸/膦酸基的药理活性分子。

Drugs covered by this patent

Patent Metadata

Patent number
CN108129514A
Jurisdiction
CN
Classification
—
Expires
2018-06-08
Drug substance claim
No
Drug product claim
No
Assignee
BEIJING MEIBEITA PHARMACEUTICAL RESEARCH Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.